Chronic kidney disease (CKD) affects more than 30 million people in the United States[@bib1] and is associated with cardiovascular morbidity and increased mortality.[@bib2] Risk modification (ie, glycemic control, blood pressure control, and avoidance of nephrotoxic substances) can decrease CKD-associated morbidity, including progression to end-stage kidney disease (ESKD), and mortality.[@bib3], [@bib4], [@bib5] Such risk modification is presumed to rely heavily on patient understanding of disease, engagement in health care, and empowerment to participate in healthy lifestyles. National efforts have tried to increase individual awareness of CKD with the assumption that increased awareness would lead to improved health outcomes.[@bib6], [@bib7] Paradoxically, studies have demonstrated that CKD awareness is not associated with participation in healthy behaviors,[@bib8] achievement of risk-reduction targets, such as blood pressure control or use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers,[@bib9] or slower CKD progression.[@bib10] Reasons for these observations are likely multifactorial, including the way in which CKD awareness has been ascertained in these studies.

Prior work has suggested that the prevalence of CKD awareness differs by how the question is asked.[@bib11] In one study of English- and Spanish-speaking adults receiving primary care at an urban safety-net hospital in the western United States, CKD awareness was ascertained using the question in the National Health and Nutrition Examination Survey (NHANES): "Have you ever been told by a doctor or health care provider that you have weak or failing kidneys (excluding stones, bladder infections, or incontinence)?" and additional questions asking whether patients had been told about "kidney disease," "protein in the urine," "kidney problem," or that "your kidneys are damaged." The sensitivity of each CKD awareness question ranged from 26.4% for "kidney damage" to 33.2% for "weak or failing kidneys" to 40.1% for "kidney problem."[@bib11] These data suggested that the NHANES question used for national estimates was relatively insensitive to identify awareness of CKD among patients engaged with a health care system and that actual awareness of CKD using different verbiage was potentially higher than anticipated.

To determine whether these prior results are generalizable to other groups and thus should inform changes in the way in which CKD awareness is ascertained nationally, we examined the sensitivity and specificity of different ways to ascertain CKD awareness among diverse community-dwelling adults who were not necessarily engaged in primary care.

Methods {#sec1}
=======

Study Design and Participants {#sec1.1}
-----------------------------

This was a cross-sectional study of individual awareness of CKD among participants who completed wave 4 of the Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS) Study. The purpose of HANDLS was to identify the influences and interaction of race and socioeconomic status on the development of cardiovascular and cerebrovascular health disparities. HANDLS participants are community-dwelling African Americans and whites aged 30 to 64 years at enrollment drawn from 12 neighborhoods, each of which is composed of contiguous US census tracts in Baltimore City that reflect socioeconomic and racial diversity. Methods for recruitment in HANDLS have been detailed elsewhere.[@bib12]

Overall, 3,720 participants between the ages of 30 and 64 years were recruited into HANDLS between August 2004 and March 2009. They all participated in a wave 1 (baseline) study visit and were invited to participate in follow-up visits every 3 years. Wave 2 visits occurred between April 2006 and October 2011 and provided interim contact with participants, as well as updated health-related information. Wave 3 visits occurred between June 2009 and July 2013 and consisted of the first in-person follow-up visits per protocol. Wave 4 visits occurred between September 2013 and September 2017 ([Fig S1](#appsec1){ref-type="sec"}). Wave 3 and wave 4 visits consisted of health examinations, a telephone dietary recall, kidney function assessments, evaluation of the subjective experience of diabetes mellitus, and participation in other optional studies. Approximately 58% of the original cohort (n = 2171) had a wave 4 visit, during which data were collected for this ancillary study. Our study population excluded individuals missing serum creatinine and urine albuminuria values (n = 108), as well as those with an estimated glomerular filtration rate (eGFR) \< 15 mL/min/1.73 m^2^ (n = 17) at wave 4, for a total study population of 2,046.

The National Institute of Environmental Health Sciences, National Institutes of Health, approved the study protocol, as did the University of California, San Francisco Institutional Review Board (\#10-02885). All participants provided written informed consent to participate.

Data Collection and Definitions {#sec1.2}
-------------------------------

The primary predictor was individual awareness of CKD ascertained by a trained interviewer. In wave 1, CKD awareness was asked with the following question: "Have you ever been told by a doctor or health care provider that you have weak kidneys, failing kidneys, or kidney disease?" In wave 4, participants were asked: "Have you ever been told by a doctor or health care professional that" ... "you have kidney disease," "protein in the urine," "a kidney problem," and "kidney damage?" These 4 different questions (with the same mentioned question stem) were chosen because they were used in a prior single-site study.[@bib11] As part of this ancillary study, these questions were intermixed with other questions about self-rated health (asked per original HANDLS protocol) and were asked in the same order for each participant.

Self-reported demographic information (age, sex, race, educational attainment, health insurance, annual household income, and comorbid conditions) was obtained by interview during wave 1. Health literacy was determined using the short Test of Functional Health Literacy in Adults (TOFHLA) during wave 3, using a cutoff score of 60 to differentiate between individuals with adequate versus inadequate literacy levels.[@bib13] Reading level was ascertained using the Wide Range Achievement Test--3 (WRAT3) during wave 3; individuals with scores \> 40 were considered to have at least an 8th grade reading level.[@bib14]

Physical examination (blood pressure, height, and weight) and laboratory measures (serum creatinine, urine microalbumin, serum glycated hemoglobin, and fasting glucose) were obtained during wave 4. Each participant underwent sitting and standing blood pressure measurements on each arm using the brachial artery auscultation method with an inflatable cuff of appropriate size. Hypertension was defined as an average seated systolic blood pressure \> 140 mm Hg, an average seated diastolic blood pressure \> 90 mm Hg, a history of blood pressure medication use, and/or a self-report of hypertension. Diabetes was defined as a fasting glucose level \> 126 mg/dL, self-report of diabetes, or use of diabetic medication. CKD was defined by single values of eGFR \< 60 mL/min/1.73 m^2^ calculated using the CKD-EPI (CKD Epidemiology Collaboration) equation,[@bib15] or a urine microalbumin-creatinine ratio \> 30 mg/g.[@bib16]

Statistical Analysis {#sec1.3}
--------------------

Characteristics of participants were compared by CKD status using χ^2^, analysis of variance, and Mann-Whitney-Wilcoxon tests as appropriate. Using laboratory measurements as the gold standard, sensitivity (true positive rate or the proportion of participants with CKD who answered yes correctly, otherwise known as CKD awareness) and specificity (true negative rate or the proportion of participants without CKD who answered no correctly) of each awareness question were calculated for the entire study population. Then logistic regression analysis was used to determine the independent associations of sociodemographic characteristics (age, sex, race, educational attainment, poverty level, insurance status, regular source of health care, literacy status, and reading level) and comorbid conditions (diabetes, hypertension, and CKD stage) with awareness of CKD in the entire cohort, defined as a correct "yes" answer to any of the CKD awareness questions.

Model 1 included age, sex, race, educational attainment, poverty status, health insurance status, and regular source of health care. Model 2 included age, sex, race, other variables from model 1 that were moderately associated with awareness at *P* \< 0.20, and reading level and health literacy status. Model 3 included age, race, sex, other variables from model 2 that were moderately associated with awareness at *P* \< 0.20, and comorbid conditions. Calculations of sensitivity for each awareness question were then performed separately among subgroups of the study population, stratified by the variables moderately associated with CKD awareness (*P* \< 0.2) in the final logistic regression model (model 3). STATA, version 14.2 (StataCorp LLC), was the statistical software used for this analysis.

Results {#sec2}
=======

Study Participants {#sec2.1}
------------------

Among the study population of 2,046 people, mean (SD) age was 56.5 (9.1) years, 41.5% were men, 38.7% were white, and 61.3% were African American. Nearly one-third did not complete their high school education, 16.9% had low health literacy, and 39.5% had lower than an 8th grade reading level. More than 40% lived below the 125% national poverty level, 64.8% reported having health insurance, and 63.2% cited a regular source of health care. Compared with individuals without kidney disease (n = 1,622), individuals with CKD (n = 424) were slightly older (60.1 vs 55.5 years; *P* = 0.001), more likely to be African American and poor, and have low health literacy and a reading level below 8th grade ([Table 1](#tbl1){ref-type="table"}). Nearly one-quarter of the overall cohort carried a diagnosis of diabetes and 64% had hypertension. The proportion of individuals with both these comorbid conditions was higher among individuals with CKD (diabetes, 46.5% vs 18.5%; hypertension, 86.2% vs 59.2%; *P* = 0.001 for both comparisons) compared with those without CKD ([Table 1](#tbl1){ref-type="table"}).Table 1Characteristics of the Healthy Aging in Neighborhoods of Diversity Across the Life Span Study PopulationCharacteristicsAll (N = 2,046)No CKD (N = 1,622)CKD (N = 424)Age, y56.5 (9.1)55.6 (9.0)60.1 (8.6)Male sex850 (41.5%)672 (41.4%)178 (42.0%)Race/ethnicity White792 (38.7%)662 (40.8%)130 (30.7%) African American1,254 (61.3%)960 (59.2%)294 (69.3%)Educational attainment \<High school657 (32.8%)509 (32.2%)148 (35.3%) High school graduate1,089 (54.4%)858 (54.3%)231 (55.1%) College graduate254 (12.7%)214 (13.5%)40 (9.6%)Poverty (\<125% poverty level)825 (40.3%)627 (38.7%)198 (46.7%)Low health literacy260 (16.9%)195 (15.8%)65 (21.5%)\<8th grade reading level787 (39.5%)603 (38.1%)184 (45.1%)Health insurance1,326 (64.8%)1,036 (63.9%)290 (68.4%)Regular source of health care1,266 (63.2%)978 (61.8%)288 (68.7%)Diagnosed diabetes496 (24.3%)299 (18.4%)197 (46.5%)Diagnosed hypertension1,319 (64.7%)956 (59.2%)363 (86.2%)Hemoglobin A~1c~, %6.2 (1.3)6.0 (1.1)6.8 (1.9)SBP, mm Hg117.3 (20.3)116.2 (19.1)121.4 (23.8)DBP, mm Hg65.5 (11.3)65.4 (10.6)66.0 (13.2)eGFR, mL/min/1.73 m^2^87.9 (19.9)92.0 (15.4)72.0 (26.3)eGFR \< 60 mL/min/1.73 m^2^193 (9.3%)0 (0%)193 (45.5%)Albuminuria, mg/g5.4 \[3.5-12.8\]4.7 \[3.2-7.7\]55.3 \[16.2-146.5\]Albuminuria \> 30 mg/g295 (14.4%)0 (0%)295 (70.2%)[^1][^2]

Sensitivity/Specificity of CKD Awareness Questions {#sec2.2}
--------------------------------------------------

Sensitivities of single CKD awareness questions ranged from 2.2% for "kidney damage" to 5.2% for "kidney problem." Sensitivity of the compound question asking about "weak kidneys, failing kidneys, or kidney disease" was 19.5%. Specificities ranged from 94.2% for the compound question to 99.8% for "protein in the urine" ([Table 2](#tbl2){ref-type="table"}).Table 2Sensitivity and Specificity of Different Questions Ascertaining CKD AwarenessAwareness QuestionOverall CohortTrue Positive: SensitivityTrue Negative: SpecificityDiagnosed with weak kidneys, failing kidneys, or kidney disease19.5% (82/421)94.2% (1,553/1,649)Kidney problem5.2% (21/405)99.6% (1,556/1,562)Kidney disease2.5% (10/408)99.7% (1,596/1,601)Kidney damage2.2% (9/408)99.5% (1,594/1,601)Protein in the urine[a](#tbl2fna){ref-type="table-fn"}2.5% (7/284)99.8% (1,653/1,656)[^3][^4]

In multivariate logistic regression, awareness of CKD using any of the questions was moderately associated with higher (more severe) CKD stage, inadequate health literacy status, greater poverty status, and having insurance ([Table 3](#tbl3){ref-type="table"}). Sensitivity of each awareness question was then calculated among subgroups of the study population, stratified by the mentioned variables that were moderately associated with CKD awareness ([Table 4](#tbl4){ref-type="table"}).Table 3Independent Associations of Sociodemographic Variables and Comorbid Conditions With Awareness of CKD, Defined by a Correct Response to Any of the CKD Awareness QuestionsVariableModel 1Model 2Model 3Odds Ratio (95% CI)Odds Ratio (95% CI)Odds Ratio (95% CI)Age, per y1.05 (1.02-1.08)[a](#tbl3fna){ref-type="table-fn"}1.06 (1.03-1.10)[a](#tbl3fna){ref-type="table-fn"}1.00 (0.96-1.04)Female sex, vs male0.99 (0.64-1.55)0.98 (0.58-1.68)0.67 (0.35-1.27)African American, vs white1.09 (0.69-1.71)1.08 (0.62-1.86)0.96 (0.52-1.79)High school graduate, vs \<high school graduate0.96 (0.60-1.52)\_\_\_\_Below 125% poverty level, vs above1.82 (1.16-2.87)[a](#tbl3fna){ref-type="table-fn"}1.92 (1.13-3.29)[a](#tbl3fna){ref-type="table-fn"}1.55 (0.85-2.81)[a](#tbl3fna){ref-type="table-fn"}Having health insurance, vs none1.53 (0.84-2.79)2.36 (1.19-4.67)[a](#tbl3fna){ref-type="table-fn"}2.05 (0.97-4.35)[a](#tbl3fna){ref-type="table-fn"}Having a regular source of health care, vs not1.13 (0.64-2.00)\_\_\_\_Above 8th grade reading level, vs below\_\_1.05 (0.58-1.84)\_\_Adequate health literacy level, vs inadequate\_\_0.56 (0.31-1.03)[a](#tbl3fna){ref-type="table-fn"}0.62 (0.32-1.20)[a](#tbl3fna){ref-type="table-fn"}Presence of diabetes\_\_\_\_1.17 (0.84-1.65)Presence of hypertension\_\_\_\_1.00 (0.40-2.50)CKD stages 3/4, vs stages 1/2\_\_\_\_2.48 (1.29-4.75)[a](#tbl3fna){ref-type="table-fn"}[^5][^6][^7]Table 4Unadjusted Sensitivities of Each Awareness Question Stratified by Severity of CKD, Poverty Level, Health Literacy Status, and Having Health Insurance**Severity of CKD**Awareness QuestionCKD Stages 1-2CKD Stages 3-4Unadjusted *P*SensitivitySensitivityDiagnosed with weak kidneys, failing kidneys, or kidney disease26/230 (11.3%)56/191 (29.3%)0.001Kidney problem5/222 (2.3%)16/183 (8.7%)0.003Kidney disease3/224 (1.3%)7/184 (3.8%)0.1Kidney damage2/224 (0.89%)7/184 (3.8%)0.05Protein in the urine^a^3/222 (1.4%)4/62 (6.45%)0.5**Poverty Level**Awareness QuestionAbove Poverty LevelBelow Poverty LevelUnadjusted *P*SensitivitySensitivityDiagnosed with weak kidneys, failing kidneys, or kidney disease36/224 (16.1%)46/197 (23.8%)0.003Kidney problem9/218 (4.1%)12/187 (6.4%)0.1Kidney disease3/221 (1.4%)6/187 (3.2%)0.9Kidney damage6/221 (2.7%)4/187 (2.1%)0.1Protein in the urine^a^3/151 (2.0%)4/133 (3.0%)0.4**Health Literacy**Awareness QuestionAdequate Health LiteracyInadequate Health LiteracyUnadjusted *P*SensitivitySensitivityDiagnosed with weak kidneys, failing kidneys, or kidney disease39/236 (16.5%)17/65 (26.2%)0.006Kidney problem6/231 (2.6%)0/62 (0.0%)0.3Kidney disease3/232 (1.3%)1/62 (1.6%)0.7Kidney damage3/232 (1.3%)0/62 (0.0%)0.4Protein in the urine^a^4/158 (2.5%)0/45 (0.0%)0.4**Health Insurance**Awareness QuestionHas Health InsuranceDoes Not Have Health InsuranceUnadjusted *P*SensitivitySensitivityDiagnosed with weak kidneys, failing kidneys, or kidney disease61/288 (21.2%)21/133 (15.8%)0.07Kidney problem13/278 (4.7%)8/127 (6.3%)0.8Kidney disease6/279 (2.1%)3/129 (2.3%)0.7Kidney damage6/279 (2.1%)4/129 (3.1%)0.9Protein in the urine[a](#tbl4fna){ref-type="table-fn"}5/190 (2.6%)2/94 (2.1%)0.7[^8][^9][^10]

Higher sensitivities of CKD awareness questions were noted among study participants with more advanced CKD. Among study participants with CKD stages 1 and 2, sensitivities ranged from 1% ("kidney damage") to 11.3% ("weak kidneys, failing kidneys, or kidney disease"). Among those with CKD stages 3 and 4, sensitivities ranged from 3.8% ("kidney disease") to 29.3% ("weak kidneys, failing kidneys, or kidney disease"). Sensitivities of the compound question "weak kidneys, failing kidneys, or kidney disease" and the questions asking about a "kidney problem" or "kidney damage" were higher among individuals with more severe CKD (*P* values ranging from 0.001 to 0.05). Only sensitivity of the compound question was higher among individuals who lived below, compared with those who lived above, the poverty level (23.8% vs 16.1%; *P* = 0.003), without statistically significant differences in sensitivities of other awareness questions by poverty level. Similarly, sensitivity of the compound question was higher among individuals with inadequate health literacy compared with those with adequate health literacy (26.2% vs 16.5%; *P* = 0.006) and among individuals with insurance compared with those without health insurance (21.1% vs 15.8%; *P* = 0.07; [Table 4](#tbl4){ref-type="table"}).

Discussion {#sec3}
==========

This population-based study has 3 key findings. First, it corroborates prior work that awareness of CKD is low among community-dwelling adults who may or may not have continuing ongoing contact with a health care delivery system.[@bib11], [@bib17], [@bib18] Second, it demonstrates that the detection of awareness among those truly having CKD varies with how the question is asked. The question currently used in national health surveys ("Have you ever been told by a doctor or health care provider that you have weak or failing kidneys \[excluding stones, bladder infections, or incontinence\]?") may be poorly estimating true CKD awareness in the general population and may be partially responsible for the divergent results between low awareness of CKD and high awareness of other common chronic diseases such diabetes, hypertension, and hypercholesterolemia. Third, it provides additional evidence that using a compound question to ascertain awareness has greater sensitivity at the expense of a modest decrease in specificity.

Low individual awareness of CKD has implications for clinical care, as well as for research. From a clinical perspective, individuals who do not know about their kidney disease may be less motivated to participate in self-management activities that are directly related to kidney health. Such activities could include medication adherence, healthy dietary patterns, tobacco cessation, and increased physical activity, among other healthy habits. Additionally, individuals who do not know that they have CKD may not know to avoid potentially nephrotoxic medications or supplements, both of which are commonly used among individuals with kidney disease.[@bib19], [@bib20] It is thus not surprising that patients with advanced CKD and ESKD wish that they had known more about their kidney disease at earlier stages.[@bib21], [@bib22] Additionally, data from some pre-ESKD programs with robust educational components have been associated with decreased incidence in dialysis, better dialysis preparation, and lower mortality, including programs that focused on individuals with less severe CKD.[@bib23], [@bib24] Ensuring that patients with CKD at highest risk for progression to ESKD are aware of their CKD and have resources to translate that awareness into action is thus one important component of CKD care delivery.

From a research perspective, low individual awareness of CKD could inhibit participation in clinical trials that seek to recruit individuals with kidney disease. This may be of particular importance for therapies aimed at changing the trajectory of kidney disease decline, which necessitate inclusion of individuals with mild-moderate kidney disease (as opposed to individuals with severe CKD), which are the populations in whom CKD awareness is lowest.[@bib25] Low awareness of kidney disease at the population level may also lead to low perceived importance of the disease and is likely one contributing factor to the lower level of federal funding set aside for kidney disease research compared with other chronic conditions[@bib26] and the relative paucity of clinical trials in nephrology compared with other medical disciplines.[@bib27]

Not only is achieving high levels of CKD awareness essential for clinical care and clinical research, but accurately measuring CKD awareness is important from the public health perspective as well. Public health care officials or insurance plan executives may launch health campaigns with the goal of promoting healthy behaviors among individuals with a specific disease.[@bib28] Change in CKD awareness at the population level, as well as self-reported participation in healthy behaviors, could be used to evaluate the success of such campaigns targeted at improving kidney health. Also, in the absence of a perfect measure of CKD awareness, the potential tradeoff between sensitivity and specificity of a measure of CKD awareness should be acknowledged. Maximizing the sensitivity of a CKD awareness metric may be important to ensure a campaign's overall reach or penetration within an at-risk population; maximizing specificity of the measure can ensure accuracy of a campaign's message. Using a metric of CKD awareness with highest sensitivity and little tradeoff with respective to specificity would be important to evaluate which local campaigns to spread at a regional or national level.

With that in mind, the most common question related to kidney disease awareness (that used in NHANES) may benefit from updating, particularly in light of the evolving terminology of kidney disease in the nephrology field. Results from our prior work suggested that individuals with CKD who responded "yes" to having "protein in the urine" were different from those who responded "yes" to having "kidney disease" or a "kidney problem."[@bib11] Using a compound question including the term kidney disease and also including a descriptor of proteinuria, in addition to the current terms used in the NHANES survey ("weak or failing kidneys"), could thus be useful in future attempts to accurately ascertain CKD awareness. One possibility could be the awareness question: "Have you ever been told by a doctor or other health provider that you have weak or failing kidneys, kidney disease, or protein in the urine?" While this question was not explicitly tested in our study, sensitivity of the one compound question in this study asking about "weak kidneys, failing kidneys, or kidney disease" was high, even among individuals who were poor and those with limited health literacy.

Educational literature suggests that compound questions may score less well with readability instruments because of their length and may be more difficult for individuals with limited health literacy to answer.[@bib29] Limited health literacy is common among patients with CKD.[@bib30], [@bib31], [@bib32] However, similar to the compound question that was tested in this study, our proposed compound question incorporates the essential elements that define CKD, has few syllables and short words, and includes terminology about kidney disease that is used in public health campaigns and educational materials from national societies and nonprofit organizations.[@bib33], [@bib34]

The results of this study should be considered within the context of its limitations. Sensitivity/specificity estimates of CKD awareness rely on single measurements of eGFR and albuminuria (similar to NHANES and other population-based studies) rather than 2 repeated measurements in clinical care. This could overestimate the number of individuals with kidney disease and underestimate CKD awareness and could potentially explain the large difference in prevalence of CKD awareness in this study compared to our prior work among individuals engaged with primary care in one health care delivery system.

Also, there was a relatively small number of study participants deemed to have CKD in the overall HANDLS cohort. HANDLS study participants completing the fourth wave of follow-up may have been more engaged in their health care than the average adult in the United States due to their participation in a longitudinal study. For example, \>64% of participants in this study cited a regular source of health care. The prevalence and distribution of sociodemographic characteristics of wave 4 study participants were not substantially different from those of HANDLS baseline study participants (including the proportion of individuals with a regular source of health care), except for a smaller proportion of college graduates and a larger percentage of individuals with less than high school education in the baseline cohort (data not shown).

The study population was representative of whites and African Americans of varying socioeconomic status residing in the Baltimore metropolitan area and thus results may not be generalizable to all US adults, particularly those residing in rural areas. Nevertheless, this study shows that by using a more sensitive combination question to ascertain CKD awareness, asking about "weak kidneys, failing kidneys, or kidney disease," estimates of CKD awareness may be closer to 20%. Given the results seen in this study population, CKD awareness may have already exceeded the Healthy People 2020 target of 13.4%.[@bib35]

In summary, we corroborate that CKD awareness is low not only in populations engaged with primary care but also among community-dwelling adults with kidney disease. We also demonstrate that we have likely met the Healthy People 2020 goal related to CKD awareness when using a more sensitive measure of awareness. Understanding the phrases about kidney disease that are most understandable to patients with and at risk for CKD and targeting the population with such language in awareness campaigns are important next steps to further improve upon awareness metrics in the United States. Devising new tools to help primary care providers discuss kidney disease is another important step. These efforts will allow us to better target future awareness messages and more accurately evaluate campaign successes.
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Figure S1Timeline of study visits for the Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS) Study.
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**Figure S1:** Timeline of study visits for the Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS) Study

[^1]: *Note:* Values expressed as mean (standard deviation), number (percent), or median \[interquartile range\]. n = 2,154 for all rows except educational attainment (total N = 2,000; no CKD n = 1,581; CKD n = 419); health literacy (total N = 1,534; no CKD n = 1,231; CKD n = 303); reading level (total N = 1,991; no CKD n = 1,583; CKD n = 408); regular source of health care (total N = 2,002; no CKD n = 1,583; CKD n = 419); diagnosed hypertension (total N = 2,037; no CKD n = 1,616; CKD n = 421); diagnosed diabetes (total N = 2,045; no CKD n = 1,621; CKD n = 424); hemoglobin A~1c~ (total N = 2,034; no CKD n = 1,617; CKD n = 417); SBP and DBP (total N = 2,028; no CKD n = 1,610; CKD n = 418); and albuminuria (total N = 2,042; no CKD n = 1,622; CKD n = 420).

[^2]: Abbreviations: CKD, chronic kidney disease; DBP, diastolic blood pressure; SBP, systolic blood pressure.

[^3]: Abbreviation: CKD, chronic kidney disease.

[^4]: Among those with proteinuria only.

[^5]: *Note:* All models are multivariate logistic regression models and include age, sex, race and variables from the prior model that were associated with awareness at *P* \< 0.2.

[^6]: Abbreviations: CI, confidence interval; CKD, chronic kidney disease.

[^7]: Variables associated with awareness with *P* \< 0.2.

[^8]: *Note: P* values identify significant differences in sensitivity of awareness questions, in unadjusted models.

[^9]: Abbreviation: CKD, chronic kidney disease.

[^10]: Among those with proteinuria only.
